Intraocular pressure (IOP) is the most important modifiable risk factor for glaucoma and
fluctuates considerably within patients over short and long time periods. Our field's …

While mean intraocular pressure (IOP) has long been known to correlate with glaucomatous
damage, the role of IOP fluctuation is less clearly defined. There is extensive evidence in the …

Purpose To study the changes in corneal endothelial cell density in eyes with normal-
tension glaucoma compared with those in controls. Methods A total of 227 subjects in three …

The pleotropic cytokine interleukin-6 (IL-6) is implicated in retinal ganglion cell (RGC)
survival and degeneration, including that associated with glaucoma. IL-6 protects RGCs …

Glaucoma is a progressive, chronic optic neuropathy characterized by a typical visual field
defects. Four main classes of topical medication are actually available on the market: beta …

Current management of glaucoma entails the medical, laser, or surgical reduction of
intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate …

While the death of retinal ganglion cells in glaucoma is frequently associated with an
elevation of intraocular pressure (IOP), the mechanisms connecting the two processes …

Purpose To determine the diurnal variations in peripapillary and macular flow density (FD),
as measured using optical coherence tomography angiography (OCTA) and to elaborate on …

Purpose: To document the continuous circadian intraocular pressure (IOP) fluctuation using
a contact lens sensor during normal daily activities, and to study the relationship between …

Glaucoma is the leading cause of irreversible blindness worldwide and the prevalence is on
the rising trend. Intraocular pressure (IOP) reduction is the mainstay of treatment. The current …